Antibodies to Herpes Simplex Types 1 and 2 in Chronic Fatigue Syndrome

References

• Mc Evedy CP, Beard AW. Royal Free epidemic of 1955: a reconsideration. BMJ 1970; 1:7–11.
   PubMed Web of Science ®Google Scholar
• Wessely S, David A, Butler S, Chalder T. The management of chronic postviral fatigue syndrome. J R Col Gen Pract 1989; 39: 26–29.
   PubMedGoogle Scholar
• Wessely S, Powell R. Fatigue syndromes: a comparison of chronic postviral fa-tigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry 1989; 52: 940–948.
   PubMed Web of Science ®Google Scholar
• Rosen SD, King JC, Wilkinson JB, Nixon PGF. Is chronic fatigue syndrome syn-onymous with effort syndrome? J Roy Soc Med 1990; 83: 761–764.
   PubMed Web of Science ®Google Scholar
• Dowsett EG, Ramsey AM, Mc Cartney RA, Bell EJ. Myalgic encephalomyelitis a persistent enteroviral infection? Postgracl Med J 1990; 66: 526–530.
   PubMed Web of Science ®Google Scholar
• Jones JF, Straus SE. Chronic Epstein-Barr virus infection. Ann Rev Med 19087; 38: 195–209.
   Google Scholar
• Kreuger GRF, Koch B, Ablashi DV. Persistent fatigue and depression in patient with antibody to human B-Iymphotropic virus. Lancet 1987; ii: 36.
   Google Scholar
• Falco J. Does a retrovirus explain fatigue syndrome puzzle? Science 1990; 249: 1240–1241.
   Web of Science ®Google Scholar
• Bond PA. A role for herpes simplex virus in the aetiology of chronic fatigue syn-drome and related disorders. Med Hypotheses 1993; 40: 301–308.
   PubMed Web of Science ®Google Scholar
• Caligiuri M, Murray C, Buchwald G et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987; 139: 3306–3313.
   PubMed Web of Science ®Google Scholar
• Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403–1410.
   PubMed Web of Science ®Google Scholar
• Murdoch JC. Cell Mediated immunity in patients with myalgic encephalo-myelitis syndrome. N Z Med J 1988; 101: 511–512.
   PubMed Web of Science ®Google Scholar
• Lloyd AR, Wakefield D, Boughton CR, Dwyer TM. Immunological abnormali-ties in chronic fatigue syndrome. Med J Aust 1989; 151: 122–124.
   PubMed Web of Science ®Google Scholar
• Whitely RJ, Lakeman AD, Nahmias AJ, Roizman B. DNA restriction enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Eng J Med 1982; 307: 1060.
   PubMed Web of Science ®Google Scholar
• Schluederberg A, Straus SE, Peterson P, Blumenthal S, Komaroff AL, Spring SB, Landay A, Buchwald D. NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. Ann Intern Med 1992; 117: 325–331.
   Google Scholar
• Holmes GP, Kaplan JE,Gantz NM et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108: 387–389.
   Google Scholar
• Richardson VJ, Botto I, Scriba M. Reinfection of guinea pigs with herpes sim-plex type 2: failure to establish a second latent infection. Can J Microbiol 1987; 33: 679–683.
   Google Scholar
• Hassan IS, Bannister BA, Akbar A, Weir W, Bofill M. A study of the immunol-ogy of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. CIM Immunol Immunopathol 1998; 87: 60–67.
   Google Scholar
• Stulting RD, Kindle JC, Nahmias AJ. Patterns of herpes simplex keratitis in in-bred mice. Invest Ophthalmol Vis Sci 1985; 26: 1360–1367.
   PubMed Web of Science ®Google Scholar
• Wander AH, Centifanto YM, Kaufman HE. Strain specificity of clinical isolates of herpes simplex virus. Arch Ophthalmol 1980; 98: 1458–61.
   PubMedGoogle Scholar
• Centifanto-Fitzgerald Y, Caldwell DR, Yates F. Herpes simplex virus: recurrent and nonrecurrent strains. Proc Soc Exp Biol Med 1987; 185: 484–492.
   PubMed Web of Science ®Google Scholar
• Javier RT, Sedeerati F, Stevens JG. Two avirulent Herpes simplex viruses gener-ate lethal recombinants in vivo. Science 1986; 234: 746–748.
   Google Scholar
• Kintner RL, Allan RW, Brandt CR. Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex type 1 strains. Arch Virol 1995; 140: 231–244.
   Google Scholar